SWOG clinical trial number
SWOG-8040

Evaluation of Combination Chemotherapy (FAM-S) vs. a Phase II Drug in Pancreatic Adenocarcinoma

Closed
Published
Abbreviated Title
Evaluation of Combination Chemotherapy (FAM-S) vs. a Phase II Drug in Pancreatic Adenocarcinoma
Activated
01/28/1981
Closed
03/16/1984

Publication Information Expand/Collapse

1993

Evaluation of combination chemotherapy and phase II agents in pancreatic adenocarcinoma: A Southwest Oncology Group Study.

RM Bukowski;TR Fleming;JS Macdonald;N Oishi;SA Taylor;LH Baker Cancer 71(2):322-325

1985

Randomized trials of combination chemotherapy vs. a Phase II drug in metastatic adenocarcinoma of the pancreas: Southwest Oncology Group study.

RM Bukowski;M Inamasu;S Taylor;TT Chen ASCO :#C-311

1984

Characteristics of long term survivors receiving chemotherapy for pancreatic adenocarcinoma in Southwest Oncology Group (SWOG) studies.

RM Bukowski ASCO #C-583